天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Chemical Reagents>Organic reagents>fatty acid>4-?Hydroxyphenylpyruvic acid
4-?Hydroxyphenylpyruvic acid
  • 4-?Hydroxyphenylpyruvic acid

4-?Hydroxyphenylpyruvic acid NEW

Price $37 $53 $127
Package 50mg 100mg 500mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: 4-?Hydroxyphenylpyruvic acid CAS No.: 156-39-8
Purity: 97.56% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

Name4-?Hydroxyphenylpyruvic acid
Description4-Hydroxyphenylpyruvic acid is an enzyme inhibitor.4-Hydroxyphenylpyruvic acid (4-HPPA) is a keto acid that is involved in the tyrosine catabolism pathway. It is a product of the enzyme (R)-4-hydroxyphenyllactate dehydrogenase (EC 1.1.1.222) and is formed during tyrosine metabolism. The conversion from tyrosine to 4-HPPA is catalyzed by tyrosine aminotransferase. Additionally, 4-HPPA can be converted to homogentisic acid which is one of the precursors to ochronotic pigment. The enzyme 4-hydroxyphenylpyruvic acid dioxygenase (HPD) catalyzes the reaction that converts 4-hydroxyphenylpyruvic acid to homogentisic acid. A deficiency in the catalytic activity of HPD is known to lead to tyrosinemia type III, an autosomal recessive disorder characterized by elevated levels of blood tyrosine and massive excretion of tyrosine derivatives into urine. It has been shown that hawkinsinuria, an autosomal dominant disorder characterized by the excretion of 'hawkinsin,' may also be a result of HPD deficiency . Moreover, 4-hydroxyphenylpyruvic acid is also found to be associated in phenylketonuria, which is also an inborn error of metabolism. There are two isomers of HPPA, specifically 4HPPA and 3HPPA, of which 4HPPA is the most common.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 50 mg/mL (277.53 mM)
Keywordsinhibit | 4 ?Hydroxyphenylpyruvic acid | Endogenous Metabolite | 4?Hydroxyphenylpyruvic acid | 4-?Hydroxyphenylpyruvic acid | Inhibitor
Inhibitors RelatedSucrose | Daidzein | Guanidine hydrochloride | Fumaric acid | Ferulic Acid | Vanillin | Formamide | Glycerol | Thymidine | Naringin | 3-Indoleacetic acid | Oleic acid
Related Compound LibrariesBioactive Compound Library | Natural Product Library | Tobacco Monomer Library | Microbial Natural Product Library | Inhibitor Library | NO PAINS Compound Library | Natural Product Library for HTS | Human Endogenous Metabolite Library | Bioactive Compounds Library Max | Gut Microbial Metabolite Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1KG
VIP3Y
Hebei Weibang Biotechnology Co., Ltd
2024-10-28
$0.00/1KG
VIP6Y
Shaanxi Dideu Medichem Co. Ltd
2024-07-22
$0.00/25KG
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-10-17
$23.00/1kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-09-11
$2.00/1KG
VIP6Y
Career Henan Chemical Co
2020-01-07
$0.00/1g
Nanjing jinheyou Trading Co., Ltd.
2019-10-31
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY